(Q53238361)

12 May 2018

title

Pharmacokinetics of the M1-agonist talsaclidine in mouse, rat, rabbit and monkey, and extrapolation to man. (English)

1 reference

12 May 2018

1 reference

Leusch A

1

1 reference

12 May 2018

Tröger W

series ordinal

2

1 reference

12 May 2018

Greischel A

series ordinal

3

1 reference

12 May 2018

Roth W

series ordinal

4

1 reference

12 May 2018

language of work or name

English

0 references

publication date

1 August 2000

1 reference

12 May 2018

published in

Xenobiotica

1 reference

12 May 2018

volume

30

1 reference

12 May 2018

issue

8

1 reference

12 May 2018

page(s)

797-813

1 reference

12 May 2018

Discriminative stimulus properties of the muscarinic receptor agonists Lu 26-046 and O-Me-THPO in rats: evidence for involvement of different muscarinic receptor subtypes

cites work

1 reference

https://api.crossref.org/works/10.1080%2F00498250050119853

Donepezil use in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250050119853

Design of [R-(Z)]-(+)-alpha-(methoxyimino)-1-azabicyclo[2.2.2]octane-3-acetonitri le (SB 202026), a functionally selective azabicyclic muscarinic M1 agonist incorporating the N-methoxy imidoyl nitrile group as a novel ester bioisostere.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250050119853

Correlation of plasma clearance of 54 extensively metabolized drugs between humans and rats: mean allometric coefficient of 0.66.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250050119853

Invited review: Cholinesterase inhibitors for Alzheimer's disease therapy: from tacrine to future applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250050119853

Interspecies scaling and comparisons in drug development and toxicokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250050119853

The cognitive psychopharmacology of Alzheimer's disease: focus on cholinergic systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250050119853

Link between drug absorption solubility and permeability measurements in Caco-2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250050119853

Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250050119853

A bridging study of LU 25-109 in patients with probable Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250050119853

Specificity of transporters for 'organic anions' and 'organic cations' in the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250050119853

Tacrine in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250050119853

Physiological parameters in laboratory animals and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250050119853

10.1080/00498250050119853

21 January 2018

Identifiers

DOI

1 reference

12 May 2018

1 reference

12 May 2018